Product NDC: | 0037-4401 |
Proprietary Name: | Depen |
Non Proprietary Name: | Penicillamine |
Active Ingredient(s): | 250 mg/1 & nbsp; Penicillamine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0037-4401 |
Labeler Name: | Meda Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019854 |
Marketing Category: | NDA |
Start Marketing Date: | 19781130 |
Package NDC: | 0037-4401-01 |
Package Description: | 100 TABLET in 1 BOTTLE (0037-4401-01) |
NDC Code | 0037-4401-01 |
Proprietary Name | Depen |
Package Description | 100 TABLET in 1 BOTTLE (0037-4401-01) |
Product NDC | 0037-4401 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Penicillamine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19781130 |
Marketing Category Name | NDA |
Labeler Name | Meda Pharmaceuticals Inc. |
Substance Name | PENICILLAMINE |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antirheumatic Agent [EPC] |